Fundraising Fox
/Companies
Sign in

AGC Biologics

Seattle, US · 2 known investors

Find your way into AGC Biologics

Sign up to see every warm intro you have to AGC Biologics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AGC Biologics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.

Advanced ManufacturingBiotechEnterprise SoftwareHealthtechMedical Devices

Founders & leadership

ASAlberto Santagostino
Alberto SantagostinoChief Executive Officer and PresidentAlberto Santagostino is Chief Executive Officer and President of AGC Biologics, a contract development and manufacturing organization providing biopharmaceutical manufacturing services.
KMKasper Møller
Kasper MøllerChief Technical Officer and Executive Vice President, Europe & Japan RegionsChief Technical Officer and Executive Vice President, Europe & Japan Regions at Agcbio
CWChristoph Winterhalter
Christoph WinterhalterChief Business OfficerChristoph Winterhalter is Chief Business Officer of AGC Biologics, a contract development and manufacturing organization for biopharmaceuticals. He has more than 20 years of experience in life sciences across Europe and the US, including general management and P&L responsibility for biologics CDMO operations, global sales leadership, and key account management with multinational pharmaceutical companies.
YT
Yuichiro TashiroExecutive Vice President, Corporate FunctionsExecutive Vice President, Corporate Functions at Agcbio
CMCarrie Mygatt
Carrie MygattExecutive Vice President, Finance
LALuca Alberici
Luca AlbericiExecutive Vice President, Global Cell & Gene Technologies and General Manager, Milan FacilityExecutive Vice President, Global Cell & Gene Technologies and General Manager, Milan Facility at Agcbio
KY
Kohei YokoyamaExecutive Vice President, Region Japan Facilitator
MAMotoi Aoki
Motoi AokiHead of Global Quality

Investors · 2

European Equity Partnerslisted by European Equity PartnersGuernsey · $540K – $10.8M

Frequently asked questions

What does AGC Biologics do?
AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.
Who are AGC Biologics's investors?
AGC Biologics's investors include Boulder Ventures, European Equity Partners.
Where is AGC Biologics headquartered?
AGC Biologics is headquartered in Seattle, US.